Phase II study of first-line sagopilone plus prednisone in patients with castration-resistant prostate cancer: A phase II study of the Department of Defense Prostate Cancer Clinical Trials Consortium

T. M. Beer, D. C. Smith, A. Hussain, M. Alonso, J. Wang, M. Giurescu, K. Roth, Y. Wang

    Research output: Contribution to journalArticlepeer-review

    17 Scopus citations

    Fingerprint

    Dive into the research topics of 'Phase II study of first-line sagopilone plus prednisone in patients with castration-resistant prostate cancer: A phase II study of the Department of Defense Prostate Cancer Clinical Trials Consortium'. Together they form a unique fingerprint.

    Medicine & Life Sciences